Psychedelics Alberta university kicks off major study on psilocybin for alcohol use disorder treatment Filament Health will supply psilocybin for what University of Calgary says is Canada's 'largest single-site clinical trial' of its kind Rowan DunneMarch 21, 2024
Industry update MagicMed attracts investors to advance library of psychedelic derivatives After raising $8.1M, the Calgary company filed 12 patents and launched a candidate selection program for novel psychedelic mental health treatments Jared GnamDecember 23, 2020
Investment Ideas MagicMed aims to mainstream psychedelic therapy with world’s largest ‘Psybrary’ Through its university partnership, the firm wants to attract big pharma backers by making 100,000s of novel psychedelic derivatives for new precision medicine Jared GnamDecember 1, 2020